| 3-mos. on/3 mos. off Forteo: report released
Below is a link to an abstract of the NEJM August 11, 2005, article about the Helen Hayes Hospital study of potential benefits to taking PTH 1-34 daily vs in three months on/three months off cycles. Interestingly enough, the subjects in the study had been on prior Fosamax therapy and continued to take it during the course of the study.
Guess what: Daily vs cyclic administration made little difference in the end, if I understand the conclusions correctly. Early-on findings that bone resorption increased in the daily-treatment group suggested that cyclic administration was preferable.
Hmm...
[url]http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=16093465&query_hl=2[/url]
Last edited by PatNJ; 08-19-2005 at 01:21 PM.
|